Shay JW and Wright WE: Hallmarks of telomeres in ageing research. J Pathol. 211:114–123. 2007. View Article : Google Scholar

Pańczyszyn A, Boniewska-Bernacka E and Goc A: The role of telomeres and telomerase in the senescence of postmitotic cells. DNA Repair (Amst). 95:1029562020. View Article : Google Scholar

Smith EM, Pendlebury DF and Nandakumar J: Structural biology of telomeres and telomerase. Cell Mol Life Sci. 77:61–79. 2020. View Article : Google Scholar

Ameh OI, Okpechi IG, Dandara C and Kengne AP: Association between telomere length, chronic kidney disease, and renal traits: A systematic review. OMICS. 21:143–155. 2017. View Article : Google Scholar

Bolignano D, Mattace-Raso F, Sijbrands EJ and Zoccali C: The aging kidney revisited: A systematic review. Ageing Res Rev. 14:65–80. 2014. View Article : Google Scholar

Sitaram RT, Cairney CJ, Grabowski P, Keith WN, Hallberg B, Ljungberg B and Roos G: The PTEN regulator DJ-1 is associated with hTERT expression in clear cell renal cell carcinoma. Int J Cancer. 125:783–790. 2009. View Article : Google Scholar

Svenson U, Gronlund E, Soderstrom I, Sitaram RT, Ljungberg B and Roos G: Telomere length in relation to immunological parameters in patients with renal cell carcinoma. PLoS One. 8:e555432013. View Article : Google Scholar

Melk A, Schmidt BM, Takeuchi O, Sawitzki B, Rayner DC and Halloran PF: Expression of p16INK4a and other cell cycle regulator and senescence associated genes in aging human kidney. Kidney Int. 65:510–520. 2004. View Article : Google Scholar

de Lange T: A loopy view of telomere evolution. Front Genet. 6:3212015. View Article : Google Scholar

Wood AM, Laster K, Rice EL and Kosak ST: A beginning of the end: New insights into the functional organization of telomeres. Nucleus. 6:172–178. 2015. View Article : Google Scholar

de Lange T: Protection of mammalian telomeres. Oncogene. 21:532–540. 2002. View Article : Google Scholar

Nagpal N and Agarwal S: Telomerase RNA processing: Implications for human health and disease. Stem Cells. 2020.(Epub ahead of print). View Article : Google Scholar

Serakinci N, Graakjaer J and Kolvraa S: Telomere stability and telomerase in mesenchymal stem cells. Biochimie. 90:33–40. 2008. View Article : Google Scholar

Blagoev KB: Cell Proliferation in the presence of telomerase. PLoS One. 4:e26222009. View Article : Google Scholar

Cong YS, Wright WE and Shay JW: Human telomerase and its regulation. Microbiol Mol Biol Rev. 66:407–425, table of contents. 2002. View Article : Google Scholar

Buseman CM, Wright WE and Shay JW: Is telomerase a viable target in cancer? Mutat Res. 730:90–97. 2012. View Article : Google Scholar

Melk A, Kittikowit W, Sandhu I, Halloran KM, Grimm P, Schmidt BMW and Halloran PF: Cell senescence in rat kidneys in vivo increases with growth and age despite lack of telomere shortening. Kidney Int. 63:2134–2143. 2003. View Article : Google Scholar

Li Y and Lerman LO: Cellular senescence: A new player in kidney injury. Hypertension. 76:1069–1075. 2020. View Article : Google Scholar

Kato S, Shiels PG, McGuinness D, Lindholm B, Stenvinkel P, Nordfors L, Qureshi AR, Yuzawa Y, Matsuo S and Maruyama S: Telomere attrition and elongation after chronic dialysis initiation in patients with end-stage renal disease. Blood Purif. 41:25–33. 2016. View Article : Google Scholar

Perico N, Remuzzi G and Benigni A: Aging and the kidney. Curr Opin Nephrol Hypertens. 20:312–317. 2011. View Article : Google Scholar

Abdel-Rahman EM and Okusa MD: Effects of aging on renal function and regenerative capacity. Nephron Clin Pract. 127:15–20. 2014. View Article : Google Scholar

Wills LP and Schnellmann RG: Telomeres and telomerase in renal health. J Am Soc Nephrol. 22:39–41. 2011. View Article : Google Scholar

Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, DePinho RA and Greider CW: Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell. 91:25–34. 1997. View Article : Google Scholar

Wright WE and Shay JW: Telomere dynamics in cancer progression and prevention: Fundamental differences in human and mouse telomere biology. Nat Med. 6:849–851. 2000. View Article : Google Scholar

Kloda K, Domanski L, Kwiatkowska E, Borowiecka E, Safranow K, Drozd A, Ciechanowicz A, Maciejewska-Karłowska A, Sawczuk M, Pawlik A and Ciechanowski K: hTERT, BICD1 and chromosome 18 polymorphisms associated with telomere length affect kidney allograft function after transplantation. Kidney Blood Press Res. 40:111–120. 2015. View Article : Google Scholar

O'Hare AM, Bertenthal D, Walter LC, Garg AX, Covinsky K, Kaufman JS, Rodriguez RA and Allon M: When to refer patients with chronic kidney disease for vascular access surgery: Should age be a consideration? Kidney Int. 71:555–561. 2007. View Article : Google Scholar

Verzola D, Gandolfo MT, Gaetani G, Ferraris A, Mangerini R, Ferrario F, Villaggio B, Gianiorio F, Tosetti F, Weiss U, et al: Accelerated senescence in the kidneys of patients with type 2 diabetic nephropathy. Am J Physiol Renal Physiol. 295:F1563–F1573. 2008. View Article : Google Scholar

Lindeman RD, Tobin J and Shock NW: Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc. 33:278–285. 1985. View Article : Google Scholar

Chow WH, Dong LM and Devesa SS: Epidemiology and risk factors for kidney cancer. Nat Rev Urol. 7:245–257. 2010. View Article : Google Scholar

Klatte T, Rossi SH and Stewart GD: Prognostic factors and prognostic models for renal cell carcinoma: A literature review. World J Urol. 36:1943–1952. 2018. View Article : Google Scholar

Morais M, Dias F, Teixeira AL and Medeiros R: Telomere length in renal cell carcinoma: The Jekyll and Hyde biomarker of ageing of the kidney. Cancer Manag Res. 12:1669–1679. 2020. View Article : Google Scholar

Pal D, Sharma U, Singh SK, Kakkar N and Prasad R: Inhibition of hTERT expression by MAP kinase inhibitor induces cell death in renal cell carcinoma. Urol Oncol. 35:401–408. 2017. View Article : Google Scholar

Wu X, Amos CI, Zhu Y, Zhao H, Grossman BH, Shay JW, Luo S, Hong WK and Spitz MR: Telomere dysfunction: A potential cancer predisposition factor. J Natl Cancer Inst. 95:1211–1218. 2003. View Article : Google Scholar

Mehle C, Ljungberg B and Roos G: Telomere shortening in renal cell carcinoma. Cancer Res. 54:236–241. 1994.

Gisselsson D, Gorunova L, Hoglund M, Mandahl N and Elfving P: Telomere shortening and mitotic dysfunction generate cytogenetic heterogeneity in a subgroup of renal cell carcinomas. Br J Cancer. 91:327–332. 2004. View Article : Google Scholar

Carrozza F, Santoni M, Piva F, Cheng L, Lopez-Beltran A, Scarpelli M, Montironi R, Battelli N and Tamberi S: Emerging immunotherapeutic strategies targeting telomerases in genitourinary tumors. Crit Rev Oncol Hematol. 131:1–6. 2018. View Article : Google Scholar

Svenson U, Ljungberg B and Roos G: Telomere length in peripheral blood predicts survival in clear cell renal cell carcinoma. Cancer Res. 69:2896–2901. 2009. View Article : Google Scholar

Demanelis K, Jasmine F, Chen LS, Chernoff M, Tong L, Delgado D, Zhang C, Shinkle J, Sabarinathan M, Lin H, et al: Determinants of telomere length across human tissues. Science. 369:eaaz68762020. View Article : Google Scholar

Aramburu T, Plucinsky S and Skordalakes E: POT1-TPP1 telomere length regulation and disease. Comput Struct Biotechnol J. 18:1939–1946. 2020. View Article : Google Scholar

Pal D, Singh SK, Kakkar N and Prasad R: Expression of telomere binding proteins (RAP1 and POT1) in renal cell carcinoma and their correlation with clinicopathological parameters. Indian J Clin Biochem. 32:301–305. 2017. View Article : Google Scholar

Dahse R, Fiedler W, Junker K, Schlichter A, Schubert J and Claussen U: Telomerase activity and telomere lengths: Alterations in renal cell carcinomas. Kidney Int. 56:1289–1290. 1999. View Article : Google Scholar

Sugimura K, Yoshida N, Hisatomi H, Nakatani T and Ikemoto S: Telomerase activity in human renal cell carcinoma. BJU Int. 83:693–697. 1999. View Article : Google Scholar

Tonelli M and Riella MC: Chronic kidney disease and the aging population. Kidney Int. 85:487–491. 2014. View Article : Google Scholar

Kremers WK, Denic A, Lieske JC, Alexander MP, Kaushik V, Elsherbiny HE, Chakkera HA, Poggio ED and Rule AD: Distinguishing age-related from disease-related glomerulosclerosis on kidney biopsy: The aging kidney anatomy study. Nephrol Dial Transplant. 30:2034–2039. 2015. View Article : Google Scholar

Nitta K, Okada K, Yanai M and Takahashi S: Aging and chronic kidney disease. Kidney Blood Press Res. 38:109–120. 2013. View Article : Google Scholar

Cañadas-Garre M, Anderson K, Cappa R, Skelly R, Smyth LJ, McKnight AJ and Maxwell AP: Genetic susceptibility to chronic kidney disease-some more pieces for the heritability puzzle. Front Genet. 10:4532019. View Article : Google Scholar

Tonelli M and Riella M: Chronic kidney disease and the aging population. J Cross Cult Gerontol. 29:231–237. 2014. View Article : Google Scholar

Mazidi M, Rezaie P, Covic A, Malyszko J, Rysz J, Kengne AP and Banach M: Telomere attrition, kidney function, and prevalent chronic kidney disease in the United States. Oncotarget. 8:80175–80181. 2017. View Article : Google Scholar

Kidir V, Aynali A, Altuntas A, Inal S, Aridogan B and Sezer MT: Telomerase activity in patients with stage 2–5D chronic kidney disease. Nefrologia. 37:592–597. 2017.(In English and Spanish). View Article : Google Scholar

Tsirpanlis G, Chatzipanagiotou S, Boufidou F, Kordinas V, Alevyzaki F, Zoga M, Kyritsis I, Stamatelou K, Triantafyllis G and Nicolaou C: Telomerase activity is decreased in peripheral blood mononuclear cells of hemodialysis patients. Am J Nephrol. 26:91–96. 2006. View Article : Google Scholar

Sell DR and Monnier VM: End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen. J Clin Invest. 85:380–384. 1990. View Article : Google Scholar

Wong LS, van der Harst P, de Boer RA, Codd V, Huzen J, Samani NJ, Hillege HL, Voors AA, van Gilst WH, Jaarsma T and van Veldhuisen DJ: Renal dysfunction is associated with shorter telomere length in heart failure. Clin Res Cardiol. 98:629–634. 2009. View Article : Google Scholar

Kooman JP, Dekker MJ, Usvyat LA, Kotanko P, van der Sande FM, Schalkwijk CG, Shiels PG and Stenvinkel P: Inflammation and premature aging in advanced chronic kidney disease. Am J Physiol Renal Physiol. 313:F938–F950. 2017. View Article : Google Scholar

Hu MC, Kuro-o M and Moe OW: Klotho and chronic kidney disease. Contrib Nephrol. 180:47–63. 2013. View Article : Google Scholar

Vlassara H, Torreggiani M, Post JB, Zheng F, Uribarri J and Striker GE: Role of oxidants/inflammation in declining renal function in chronic kidney disease and normal aging. Kidney Int Suppl. S3-11:2009.

Wynn TA and Ramalingam TR: Mechanisms of fibrosis: Therapeutic translation for fibrotic disease. Nat Med. 18:1028–1040. 2012. View Article : Google Scholar

Rockey DC, Bell PD and Hill JA: Fibrosis-a common pathway to organ injury and failure. N Engl J Med. 372:1138–1149. 2015. View Article : Google Scholar

Vaglio A, Salvarani C and Buzio C: Retroperitoneal fibrosis. Lancet. 367:241–251. 2006. View Article : Google Scholar

Sziksz E, Pap D, Lippai R, Béres NJ, Fekete A, Szabó AJ and Vannay Á: Fibrosis related inflammatory mediators: Role of the IL-10 cytokine family. Mediators Inflamm. 2015:7646412015. View Article : Google Scholar

Nowakowski ACH: Cystic fibrosis kidney disease: 10 Tips for clinicians. Front Med (Lausanne). 5:2422018. View Article : Google Scholar

Piñeiro-Hermida S, Autilio C, Martínez P, Bosch F, Pérez-Gil J and Blasco MA: Telomerase treatment prevents lung profibrotic pathologies associated with physiological aging. J Cell Biol. 219:e2020021202020. View Article : Google Scholar

Sangaralingham SJ, Wang BH, Huang L, Kumfu S, Ichiki T, Krum H and Burnett JC Jr: Cardiorenal fibrosis and dysfunction in aging: Imbalance in mediators and regulators of collagen. Peptides. 76:108–114. 2016. View Article : Google Scholar

Cianciolo RE, Benali SL and Aresu L: Aging in the canine kidney. Vet Pathol. 53:299–308. 2016. View Article : Google Scholar

Naesens M: Replicative senescence in kidney aging, renal disease, and renal transplantation. Discov Med. 11:65–75. 2011.

Turner KJ, Vasu V and Griffin DK: Telomere biology and human phenotype. Cells. 8:732019. View Article : Google Scholar

Yang L, Besschetnova TY, Brooks CR, Shah JV and Bonventre JV: Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med. 16:535–543, 531p following 143. 2010. View Article : Google Scholar

Ronco C, Bellomo R and Kellum JA: Acute kidney injury. Lancet. 394:1949–1964. 2019. View Article : Google Scholar

Ishani A, Xue JL, Himmelfarb J, Eggers PW, Kimmel PL, Molitoris BA and Collins AJ: Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol. 20:223–228. 2009. View Article : Google Scholar

Epel ES, Lin J, Dhabhar FS, Wolkowitz OM, Puterman E, Karan L and Blackburn EH: Dynamics of telomerase activity in response to acute psychological stress. Brain Behav Immun. 24:531–539. 2010. View Article : Google Scholar

Kiecolt-Glaser JK and Glaser R: Psychological stress, telomeres, and telomerase. Brain Behav Immun. 24:529–530. 2010. View Article : Google Scholar

Cheng H, Fan X, Lawson WE, Paueksakon P and Harris RC: Telomerase deficiency delays renal recovery in mice after ischemia-reperfusion injury by impairing autophagy. Kidney Int. 88:85–94. 2015. View Article : Google Scholar

Zhan M, Brooks C, Liu F, Sun L and Dong Z: Mitochondrial dynamics: Regulatory mechanisms and emerging role in renal pathophysiology. Kidney Int. 83:568–581. 2013. View Article : Google Scholar

Lane RK, Hilsabeck T and Rea SL: The role of mitochondrial dysfunction in age-related diseases. Biochim Biophys Acta. 1847:1387–1400. 2015. View Article : Google Scholar

Volarevic V, Djokovic B, Jankovic MG, Harrell CR, Fellabaum C, Djonov V and Arsenijevic N: Molecular mechanisms of cisplatin-induced nephrotoxicity: A balance on the knife edge between renoprotection and tumor toxicity. J Biomed Sci. 26:252019. View Article : Google Scholar

Shin YJ, Kim TH, Won AJ, Jung JY, Kwack SJ, Kacew S, Chung KH, Lee BM and Kim HS: Age-related differences in kidney injury biomarkers induced by cisplatin. Environ Toxicol Pharmacol. 37:1028–1039. 2014. View Article : Google Scholar

Abdel-Kader K and Palevsky PM: Acute kidney injury in the elderly. Clin Geriatr Med. 25:331–358. 2009. View Article : Google Scholar

Aubert G and Lansdorp PM: Telomeres and aging. Physiol Rev. 88:557–579. 2008. View Article : Google Scholar

Westhoff JH, Schildhorn C, Jacobi C, Hömme M, Hartner A, Braun H, Kryzer C, Wang C, von Zglinicki T, Kränzlin B, et al: Telomere shortening reduces regenerative capacity after acute kidney injury. J Am Soc Nephrol. 21:327–336. 2010. View Article : Google Scholar

Schmitt R and Cantley LG: The impact of aging on kidney repair. Am J Physiol Renal Physiol. 294:F1265–F1272. 2008. View Article : Google Scholar

Andrade L, Rodrigues CE, Gomes SA and Noronha IL: Acute kidney injury as a condition of renal senescence. Cell Transplant. 27:739–753. 2018. View Article : Google Scholar

Pei Y: Diagnostic approach in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 1:1108–1114. 2006. View Article : Google Scholar

Mangolini A, de Stephanis L and Aguiari G: Role of calcium in polycystic kidney disease: From signaling to pathology. World J Nephrol. 5:76–83. 2016. View Article : Google Scholar

Perumareddi P and Trelka DP: Autosomal dominant polycystic kidney disease. Prim Care. 47:673–689. 2020. View Article : Google Scholar

McConnachie DJ, Stow JL and Mallett AJ: Ciliopathies and the kidney: A review. Am J Kidney Dis. Oct 8–2020.(Epub ahead of print). View Article : Google Scholar

Rangan GK, Tchan MC, Tong A, Wong AT and Nankivell BJ: Recent advances in autosomal-dominant polycystic kidney disease. Intern Med J. 46:883–892. 2016. View Article : Google Scholar

Iliuta IA, Kitchlu A and Pei Y: Methodological issues in clinical trials of polycystic kidney disease: A focused review. J Nephrol. 30:363–371. 2017. View Article : Google Scholar

Yaghoubian A, de Virgilio C, White RA and Sarkisyan G: Increased incidence of renal cysts in patients with abdominal aortic aneurysms: A common pathogenesis? Ann Vasc Surg. 20:787–791. 2006. View Article : Google Scholar

Kolatsi-Joannou M, Bingham C, Ellard S, Bulman MP, Allen LI, Hattersley AT and Woolf AS: Hepatocyte nuclear factor-1beta: A new kindred with renal cysts and diabetes and gene expression in normal human development. J Am Soc Nephrol. 12:2175–2180. 2001.

Ta MH, Schwensen KG, Liuwantara D, Huso DL, Watnick T and Rangan GK: Constitutive renal Rel/nuclear factor-κB expression in lewis polycystic kidney disease rats. World J Nephrol. 5:339–357. 2016. View Article : Google Scholar

Bergmann C, von Bothmer J, Ortiz Bruchle N, Venghaus A, Frank V, Fehrenbach H, Hampel T, Pape L, Buske A, Jonsson J, et al: Mutations in multiple PKD genes may explain early and severe polycystic kidney disease. J Am Soc Nephrol. 22:2047–2056. 2011. View Article : Google Scholar

Hian CK, Lee CL and Thomas W: Renin-angiotensin-aldosterone system antagonism and polycystic kidney disease progression. Nephron. 134:59–63. 2016. View Article : Google Scholar

Chapman AB: Autosomal dominant polycystic kidney disease: Time for a change? J Am Soc Nephrol. 18:1399–1407. 2007. View Article : Google Scholar

Zhang W, Tan AY, Blumenfeld J, Liu G, Michaeel A, Zhang T, Robinson BD, Salvatore SP, Kapur S, Donahue S, et al: Papillary renal cell carcinoma with a somatic mutation in MET in a patient with autosomal dominant polycystic kidney disease. Cancer Genet. 209:11–20. 2016. View Article : Google Scholar

Gansevoort RT, Arici M, Benzing T, Birn H, Capasso G, Covic A, Devuyst O, Drechsler C, Eckardt KU, Emma F, et al: Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: A position statement on behalf of the ERA-EDTA working groups on inherited kidney disorders and european renal best practice. Nephrol Dial Transplant. 31:337–348. 2016. View Article : Google Scholar

Riwanto M, Kapoor S, Rodriguez D, Edenhofer I, Segerer S and Wuthrich RP: Inhibition of aerobic glycolysis attenuates disease progression in polycystic kidney disease. PLoS One. 11:e01466542016. View Article : Google Scholar

Ta MH, Schwensen KG, Foster S, Korgaonkar M, Ozimek-Kulik JE, Phillips JK, Peduto A and Rangan GK: Effects of TORC1 inhibition during the early and established phases of polycystic kidney disease. PLoS One. 11:e01641932016. View Article : Google Scholar

Couillard M, Guillaume R, Tanji N, D'Agati V and Trudel M: c-myc-induced apoptosis in polycystic kidney disease is independent of FasL/Fas interaction. Cancer Res. 62:2210–2214. 2002.

Raina R, Lou L, Berger B, Vogt B, Sao-Mai Do A, Cunningham R, Vasavada P, Herrmann K, Dell K and Simonson M: Relationship of urinary endothelin-1 with estimated glomerular filtration rate in autosomal dominant polycystic kidney disease: A pilot cross-sectional analysis. BMC Nephrol. 17:222016. View Article : Google Scholar

Kocer D, Karakukcu C, Ozturk F, Eroglu E and Kocyigit I: Evaluation of fibrosis markers: Apelin and transforming growth factor-β1 in autosomal dominant polycystic kidney disease patients. Ther Apher Dial. 20:517–522. 2016. View Article : Google Scholar

Martins DP, Souza MA, Baitello ME, Nogueira V, Oliveira CI, Pinhel MA, Caldas HC, Filho MA and Souza DR: Vascular endothelial growth factor as an angiogenesis biomarker for the progression of autosomal dominant polycystic kidney disease. Genet Mol Res. 15:2016. View Article : Google Scholar

Peda JD, Salah SM, Wallace DP, Fields PE, Grantham CJ, Fields TA and Swenson-Fields KI: Autocrine IL-10 activation of the STAT3 pathway is required for pathological macrophage differentiation in polycystic kidney disease. Dis Model Mech. 9:1051–1061. 2016. View Article : Google Scholar

de Melo AS, Dias SV, Cavalli Rde C, Cardoso VC, Bettiol H, Barbieri MA, Ferriani RA and Vieira CS: Pathogenesis of polycystic ovary syndrome: Multifactorial assessment from the foetal stage to menopause. Reproduction. 150:R11–R24. 2015. View Article : Google Scholar

Borie R, Kannengiesser C, Dupin C, Debray MP, Cazes A and Crestani B: Impact of genetic factors on fibrosing interstitial lung diseases. Incidence and clinical presentation in adults. Presse Med. 49:1040242020. View Article : Google Scholar

Ballew BJ and Savage SA: Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders. Expert Rev Hematol. 6:327–337. 2013. View Article : Google Scholar

Li H, Zhang Y, Dan J, Zhou R, Li C, Li R, Wu X, Singh SK, Chang JT, Yang J and Luo Y: p53 mutation regulates PKD genes and results in co-occurrence of PKD and tumorigenesis. Cancer Biol Med. 16:79–102. 2019. View Article : Google Scholar

Duffy MJ, Synnott NC, O'Grady S and Crown J: Targeting p53 for the treatment of cancer. Semin Cancer Biol. Jul 30–2020.(Epub ahead of print). View Article : Google Scholar

Sugarman ET, Zhang G and Shay JW: In perspective: An update on telomere targeting in cancer. Mol Carcinog. 58:1581–1588. 2019. View Article : Google Scholar